This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

REIT Set to Help Cure Cancer

NEW YORK ( TheStreet) -- Alexandria Real Estate Equities (ARE - Get Report) is an $8.2 billion (total cap) equity REIT focused on mission-critical lab and office space.

The driving force behind its life science sector is the highly sustainable revenue model that consists of multi-national pharmaceuticals, institutional research, biotech and life sciences products and services. Alexandria has a diversified portfolio, with more than 400 tenants -- about 50% of them are investment-grade.

Many of Alexandria's tenants are cutting-edge R&D firms that operate core, critical-mission assets, including companies that are developing successful treatments to major diseases; many are coming up with the next-generation treatments to cure cancer.

Since the company started in 1994 (IPO in 1997), Alexandria (headquartered in Pasadena) has become a venue for many scientific breakthroughs. Alexandria owns 173 high-quality properties (more than 16.7 million square feet) located in major cities such as Seattle, San Francisco, San Diego, Raleigh-Durham, suburban D.C. and Greater Boston. In addition, Alexandria owns properties in Canada and Asia.

At a two-day conference in New York this week, Alexandria will host an interactive platform for debate among the world's foremost visionaries to tackle the most critical global health care challenges, shaping the future of life science R&D.

Alexandria has become a catalyst for bringing together the world's foremost visionaries from industry, academia, medical centers, philanthropy, government and finance to explore how best to translate innovative discoveries into safe and effective therapies to treat cancer.

On Wednesday, I interviewed Alexandria's Founder and CEO Joel Marcus. In this exclusive video, Marcus provides details of Alexandria's strategically focused Life Science model and specifically the differentiated investment model that offers tremendous "sleep well at night" attributes.

video platformvideo managementvideo solutionsvideo player

Alexandria has assets of around $7.09 billion and Wednesday shares were trading at $64.04 (market cap of $4.6 billion). With less than 23% secured debt, Alexandria has a conservatively positioned balance sheet (debt-to-market cap of 39.24%). Last year, Alexandria achieved an investment grade rating of BBB- (from S&P).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ARE $85.66 0.00%
AAPL $110.38 0.00%
FB $92.07 0.00%
GOOG $626.91 0.00%
TSLA $247.57 0.00%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs